Bedside Ultrasonic Assessment for Gastric Content in Patients With Upper GI Bleeding Undergoing Endoscopy

Last updated: April 7, 2025
Sponsor: Loma Linda University
Overall Status: Completed

Phase

N/A

Condition

Gastrointestinal Diseases And Disorders

Gastric Ulcers

Ulcers

Treatment

Point of Care Ultrasound

Clinical Study ID

NCT05763745
5220358
  • Ages > 18
  • All Genders

Study Summary

Emerging studies have evaluated POCUS (Point of Care Ultrasound) for assessing of gastric content prior to anesthesia to reduce the risk of aspiration and demonstrated that POCUS can accurately identify presence of gastric food or fluid. Despite accumulating studies evaluating POCUS as a diagnostic modality to evaluate for gastric food content prior to anesthesia, there is no study to date that has evaluated the role of POCUS prior to endoscopy among patients with upper GI bleeding. Therefore, this study is to evaluate the diagnostic accuracy of POCUS for retained gastric content prior to endoscopy among patient hospitalized/admitted with upper GI bleeding. This study would take place at Loma Linda University Medical Center. Subjects will be any one who has upper GI bleed required EGD and age of greater than 18 years old. The study will plan for 1 year or reach 50 patients (whichever one comes first). In addition, subjects will be recruited from ED, ICU, Medicine ward by the PI, SubPI, and Collaborators. Subject will received ultrasound up to 6 hours prior the start of endoscopy. The location of Ultrasound would either take place at GI lab prior to scope or at the ward prior to transportation to GI lab or at ICU prior to endoscopy. The ultrasound would focus upper abdomen area and look for antrum. the result will be immediately read before endoscopy and fill out on the sheet before the endoscopy. Patient then proceed with endoscopy. At the end of the scope, the researcher will ask the endoscopist questions regarding how well they could see each part of the stomach in order to complete the study. Both results are compared between US and Endoscopy. Endoscopist is blinded in this study.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Age >18

  2. patient presents with hematemesis

  3. and/or melena

  4. and/or hematochezia accompanied by hemodynamic changes (pulse >100/min and/orsystolic blood pressure <100/min)

  5. Patient is scheduled for upper endoscopy due to the above.

Exclusion

Exclusion Criteria:

  1. Decline consent for study

  2. Patients with last solid meal <6 hours and clear liquids <2 hours prior to theendoscopy

  3. Prior surgery in the stomach

  4. Patient has duodenum, Ileus, or bowel obstruction

  5. patient has history of gastric cancer

Study Design

Total Participants: 50
Treatment Group(s): 1
Primary Treatment: Point of Care Ultrasound
Phase:
Study Start date:
February 10, 2023
Estimated Completion Date:
April 03, 2025

Connect with a study center

  • Loma Linda University Medical Center

    Loma Linda, California 92354
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.